• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDG 诊断面临的挑战。

The challenge of CDG diagnosis.

机构信息

UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Portugal; Portuguese Association for CDG, Lisboa, Portugal; CDG & Allies - Professionals and Patient Associations International Network (CDG & Allies - PPAIN), Portugal.

Portuguese Association for CDG, Lisboa, Portugal; CDG & Allies - Professionals and Patient Associations International Network (CDG & Allies - PPAIN), Portugal.

出版信息

Mol Genet Metab. 2019 Jan;126(1):1-5. doi: 10.1016/j.ymgme.2018.11.003. Epub 2018 Nov 9.

DOI:10.1016/j.ymgme.2018.11.003
PMID:30454869
Abstract

Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases that currently includes some 130 different types. CDG diagnosis is a challenge, not only because of this large number but also because of the huge clinical heterogeneity even within a number of CDG. In addition, the classical screening test, serum transferrin isoelectrofocusing, is only positive in about 60% of CDG, and can even become negative in some CDG particularly in PMM2-CDG, the most frequent N-glycosylation defect. In order to facilitate CDG diagnosis, we hereby provide some practical tools: (1) a list of clinical features strongly suggestive of a distinctive CDG; (2) a table of clinical, biochemical and laboratory findings reported in CDG, arranged per organ/system; (3) an overview of the affected organs/systems in each CDG; and (4) a diagnostic decision tree in face of a patient with a suspicion of CDG. Most important is to keep in mind a CDG in any unexplained syndrome, in particular when there is neurological involvement. This mini-review enumerates clinical and biochemical hallmarks of these diseases and the biochemical and genetic testing available, and provides an updated list and information on identified CDG. The main aim is to act as a CDG diagnosis simplified guide for healthcare professionals and, additionally, as an awareness and lobbying tool to help in the effectiveness and promptness of CDG diagnosis.

摘要

先天性糖基化障碍(CDG)是一组快速增长的遗传性疾病,目前包括约 130 种不同类型。CDG 的诊断具有挑战性,不仅因为数量庞大,还因为即使在一些 CDG 中也存在巨大的临床异质性。此外,经典的筛查试验,血清转铁蛋白等电聚焦,仅在约 60%的 CDG 中呈阳性,甚至在某些 CDG 中甚至会变为阴性,尤其是在最常见的 N-糖基化缺陷 PMM2-CDG 中。为了便于 CDG 的诊断,我们特此提供了一些实用工具:(1)一系列强烈提示独特 CDG 的临床特征;(2)按器官/系统排列的 CDG 中报告的临床、生化和实验室发现的表格;(3)每个 CDG 中受影响的器官/系统概述;(4)在怀疑 CDG 的患者中面临的诊断决策树。最重要的是要记住,任何无法解释的综合征中都可能存在 CDG,尤其是当存在神经系统受累时。这篇小型综述列举了这些疾病的临床和生化特征以及可用的生化和基因检测,并提供了最新的 CDG 列表和信息。主要目的是为医疗保健专业人员提供 CDG 诊断简化指南,并作为意识和游说工具,以帮助提高 CDG 诊断的有效性和及时性。

相似文献

1
The challenge of CDG diagnosis.CDG 诊断面临的挑战。
Mol Genet Metab. 2019 Jan;126(1):1-5. doi: 10.1016/j.ymgme.2018.11.003. Epub 2018 Nov 9.
2
Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.先天性糖基化障碍(CDG)的分子诊断检测:单基因检测和下一代测序 panel 检测的检出率。
Mol Genet Metab. 2013 Sep-Oct;110(1-2):78-85. doi: 10.1016/j.ymgme.2013.05.012. Epub 2013 May 28.
3
Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature.肝脏在先天性糖基化障碍(CDG)中的表现。文献系统综述
J Inherit Metab Dis. 2017 Mar;40(2):195-207. doi: 10.1007/s10545-016-0012-4. Epub 2017 Jan 20.
4
Congenital disorders of glycosylation.先天性糖基化障碍
Handb Clin Neurol. 2013;113:1737-43. doi: 10.1016/B978-0-444-59565-2.00044-7.
5
Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.I型和II型糖基化先天性疾病的表型和基因型谱。
Mol Genet Metab. 2017 Mar;120(3):235-242. doi: 10.1016/j.ymgme.2016.12.014. Epub 2017 Jan 3.
6
Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.阿根廷十年的糖基化先天性疾病筛查:病例研究与陷阱。
Pediatr Res. 2018 Dec;84(6):837-841. doi: 10.1038/s41390-018-0206-6. Epub 2018 Oct 18.
7
A Population-Based Study on Congenital Disorders of Protein N- and Combined with O-Glycosylation Experience in Clinical and Genetic Diagnosis.一项基于人群的蛋白质N-糖基化先天性疾病及合并O-糖基化疾病的临床与基因诊断经验研究
J Pediatr. 2017 Apr;183:170-177.e1. doi: 10.1016/j.jpeds.2016.12.060. Epub 2017 Jan 27.
8
Biochemical diagnosis of congenital disorders of glycosylation.先天性糖基化障碍的生化诊断。
Adv Clin Chem. 2024;120:1-43. doi: 10.1016/bs.acc.2024.03.001. Epub 2024 Apr 16.
9
Congenital disorders of glycosylation (CDG): Quo vadis?先天性糖基化障碍(CDG):何去何从?
Eur J Med Genet. 2018 Nov;61(11):643-663. doi: 10.1016/j.ejmg.2017.10.012. Epub 2017 Oct 25.
10
Congenital disorders of glycosylation: narration of a story through its patents.先天性糖基化障碍:从专利角度讲述一个故事。
Orphanet J Rare Dis. 2023 Aug 29;18(1):247. doi: 10.1186/s13023-023-02852-w.

引用本文的文献

1
Uncommon Factors Leading to Nephrotic Syndrome.导致肾病综合征的罕见因素。
Biomedicines. 2025 Aug 5;13(8):1907. doi: 10.3390/biomedicines13081907.
2
Oxr1 and Ncoa7 regulate V-ATPase to achieve optimal pH for glycosylation within the Golgi apparatus and trans-Golgi network.氧化还原调控蛋白1(Oxr1)和核受体辅激活因子7(Ncoa7)调节V型质子ATP酶,以在高尔基体和反式高尔基体网络中实现糖基化的最佳pH值。
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2505975122. doi: 10.1073/pnas.2505975122. Epub 2025 May 30.
3
A recurrent c.953A>C (p. Gln318Pro) variant in ALG11 causing congenital disorder of glycosylation in Turkish population.
在土耳其人群中,ALG11基因中一个反复出现的c.953A>C(p.Gln318Pro)变异导致糖基化先天性疾病。
Neurogenetics. 2025 May 27;26(1):46. doi: 10.1007/s10048-025-00826-7.
4
COG6-related prenatal phenotype (CDG2L): Clinico-pathological report and review of the literature.与COG6相关的产前表型(CDG2L):临床病理报告及文献综述
Mol Genet Genomic Med. 2025 Apr;13(4):e2442. doi: 10.1002/mgg3.2442.
5
Diagnostic and Therapeutic Approaches in Congenital Disorders of Glycosylation.先天性糖基化障碍的诊断与治疗方法
Handb Exp Pharmacol. 2025;288:211-241. doi: 10.1007/164_2025_745.
6
Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community.绘制先天性糖基化障碍(CDG)的诊断之旅:来自社区的见解。
Orphanet J Rare Dis. 2024 Nov 1;19(1):407. doi: 10.1186/s13023-024-03389-2.
7
A drug repurposing screen reveals dopamine signaling as a critical pathway underlying potential therapeutics for the rare disease DPAGT1-CDG.一项药物重定位筛选揭示了多巴胺信号作为潜在治疗罕见病 DPAGT1-CDG 的关键途径。
PLoS Genet. 2024 Oct 28;20(10):e1011458. doi: 10.1371/journal.pgen.1011458. eCollection 2024 Oct.
8
N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts.SRD5A3 缺陷型成纤维细胞中的 N-糖蛋白组学和蛋白质组学改变。
Glycobiology. 2024 Sep 30;34(11). doi: 10.1093/glycob/cwae076.
9
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.心肌病,一种罕见的糖基化先天性疾病表型:基线筛查和随访评估建议。
Mol Genet Metab. 2024 Aug;142(4):108513. doi: 10.1016/j.ymgme.2024.108513. Epub 2024 Jun 13.
10
Syndromic ichthyoses.综合征性鱼鳞病
Med Genet. 2023 Apr 5;35(1):23-32. doi: 10.1515/medgen-2023-2006. eCollection 2023 Apr.